Advanced Guided Diffuse Optical Tomography for Next-Generation Cancer Diagnosis and Treatment

An innovative, high-resolution, real-time guided diffuse optical tomography (DOT) system that integrates machine learning and multimodal imaging for personalized cancer diagnosis and treatment planning, revolutionizing the field of cancer care.

The original patent, 'Systems and methods of optimizing functional images of a lesion region using guided diffuse optical tomography,' provided a crucial step in cancer diagnosis using DOT. However, the limitations of the original patent, such as motion artifacts and lack of personalization, hinder its widespread adoption. The new inventive concept addresses these limitations by introducing machine learning-based motion correction, personalized treatment planning, and multimodal imaging integration, enabling more accurate and effective cancer diagnosis and treatment.

The advanced guided DOT system comprises a DOT device, a machine learning module, and a registration module. The DOT device acquires high-resolution, real-time functional data from the lesion region, while the machine learning module predicts and corrects for motion artifacts, ensuring accurate data analysis. The registration module integrates the functional data with other imaging modalities, providing a comprehensive understanding of the lesion region. The system enables personalized treatment planning by analyzing the functional images to determine the optimal treatment strategy for each patient. Additionally, the system can monitor treatment efficacy over time, providing valuable insights for healthcare providers.

The new inventive concept introduces several novel aspects, including the integration of machine learning for motion correction, personalized treatment planning, and multimodal imaging integration. These advancements overcome the limitations of the original patent, providing a more accurate, effective, and personalized approach to cancer diagnosis and treatment.

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, various imaging modalities, or different registration techniques. Additionally, the system could be adapted for use in other medical applications, such as cardiovascular disease diagnosis or neurological disorder treatment.

The advanced guided DOT system has significant commercial potential in the cancer diagnosis and treatment market, estimated to be worth billions of dollars. The system's ability to provide personalized treatment planning, accurate diagnosis, and effective treatment monitoring makes it an attractive solution for healthcare providers, medical research institutions, and pharmaceutical companies.